CIK: 0001910264 · Show all filings
Period: Q4 2021 (Next →)
Filing Date: Feb 14, 2022
Total Value ($000): $176,950 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DSGN | DESIGN THERAPEUTICS INC | 5,626,476 | $120,463 | 68.1% | $17.17 | 0.0% | COM | 25056L103 |
| — | EFFECTOR THERAPEUTICS INC | 6,822,114 | $56,487 | 31.9% | $8.28 | — | COM | 28202V108 |